These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 17130407)

  • 1. Mortality in amnestic mild cognitive impairment: a prospective community study.
    Hunderfund AL; Roberts RO; Slusser TC; Leibson CL; Geda YE; Ivnik RJ; Tangalos EG; Petersen RC
    Neurology; 2006 Nov; 67(10):1764-8. PubMed ID: 17130407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of MAPT H1 and APOE ε4 on transition from mild cognitive impairment to dementia.
    Samaranch L; Cervantes S; Barabash A; Alonso A; Cabranes JA; Lamet I; Ancín I; Lorenzo E; Martínez-Lage P; Marcos A; Clarimón J; Alcolea D; Lleó A; Blesa R; Gómez-Isla T; Pastor P
    J Alzheimers Dis; 2010; 22(4):1065-71. PubMed ID: 20930301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cognitive domain decline in healthy apolipoprotein E epsilon4 homozygotes before the diagnosis of mild cognitive impairment.
    Caselli RJ; Reiman EM; Locke DE; Hutton ML; Hentz JG; Hoffman-Snyder C; Woodruff BK; Alexander GE; Osborne D
    Arch Neurol; 2007 Sep; 64(9):1306-11. PubMed ID: 17846270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuropsychological measures in normal individuals that predict subsequent cognitive decline.
    Blacker D; Lee H; Muzikansky A; Martin EC; Tanzi R; McArdle JJ; Moss M; Albert M
    Arch Neurol; 2007 Jun; 64(6):862-71. PubMed ID: 17562935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. APOE epsilon4 is associated with impaired verbal learning in patients with MS.
    Koutsis G; Panas M; Giogkaraki E; Potagas C; Karadima G; Sfagos C; Vassilopoulos D
    Neurology; 2007 Feb; 68(8):546-9. PubMed ID: 17310023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioavailable testosterone is associated with a reduced risk of amnestic mild cognitive impairment in older men.
    Chu LW; Tam S; Lee PW; Wong RL; Yik PY; Tsui W; Song Y; Cheung BM; Morley JE; Lam KS
    Clin Endocrinol (Oxf); 2008 Apr; 68(4):589-98. PubMed ID: 17973937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Depression, apolipoprotein E genotype, and the incidence of mild cognitive impairment: a prospective cohort study.
    Geda YE; Knopman DS; Mrazek DA; Jicha GA; Smith GE; Negash S; Boeve BF; Ivnik RJ; Petersen RC; Pankratz VS; Rocca WA
    Arch Neurol; 2006 Mar; 63(3):435-40. PubMed ID: 16533972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Occurrence of cognitive impairment and dementia in the community: a 9-year-long prospective study.
    Caracciolo B; Palmer K; Monastero R; Winblad B; Bäckman L; Fratiglioni L
    Neurology; 2008 May; 70(19 Pt 2):1778-85. PubMed ID: 18184916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single- and multiple-domain amnestic mild cognitive impairment: two sides of the same coin?
    Brambati SM; Belleville S; Kergoat MJ; Chayer C; Gauthier S; Joubert S
    Dement Geriatr Cogn Disord; 2009; 28(6):541-9. PubMed ID: 20016185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ApoE genotype and cognition after subarachnoid haemorrhage: a longitudinal study.
    Louko AM; Vilkki J; Niskakangas T
    Acta Neurol Scand; 2006 Nov; 114(5):315-9. PubMed ID: 17022778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apolipoprotein E epsilon 4 allele is associated with increased atrophy in progressive mild cognitive impairment: a voxel-based morphometric study.
    Hämäläinen A; Grau-Olivares M; Tervo S; Niskanen E; Pennanen C; Huuskonen J; Kivipelto M; Hänninen T; Tapiola M; Vanhanen M; Hallikainen M; Helkala EL; Nissinen A; Vanninen RL; Soininen H
    Neurodegener Dis; 2008; 5(3-4):186-9. PubMed ID: 18322386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. APOE-related mortality: effect of dementia, cardiovascular disease and gender.
    Rosvall L; Rizzuto D; Wang HX; Winblad B; Graff C; Fratiglioni L
    Neurobiol Aging; 2009 Oct; 30(10):1545-51. PubMed ID: 18237822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential CSF butyrylcholinesterase levels in Alzheimer's disease patients with the ApoE epsilon4 allele, in relation to cognitive function and cerebral glucose metabolism.
    Darreh-Shori T; Brimijoin S; Kadir A; Almkvist O; Nordberg A
    Neurobiol Dis; 2006 Nov; 24(2):326-33. PubMed ID: 16973370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apolipoprotein E epsilon4 allele frequency in elderly depressed patients with and without cerebrovascular disease.
    Traykov L; Bayle AC; Latour F; Lenoir H; Seux ML; Hanon O; Péquignot R; Bert P; Moulin F; Cantegreil I; Wenisch E; Batouche F; Mehrabian S; Rotrou Jd; Rigaud AS
    J Neurol Sci; 2007 Jun; 257(1-2):280-3. PubMed ID: 17337010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The functional anatomy of divided attention in amnestic mild cognitive impairment.
    Dannhauser TM; Walker Z; Stevens T; Lee L; Seal M; Shergill SS
    Brain; 2005 Jun; 128(Pt 6):1418-27. PubMed ID: 15705612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. APOE genotype modulates the effect of serum calcium levels on cognitive function in old age.
    van Vliet P; Oleksik AM; Mooijaart SP; de Craen AJ; Westendorp RG
    Neurology; 2009 Mar; 72(9):821-8. PubMed ID: 19255409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cognitive function, serum BDNF levels and BDNF gene Val66Met polymorphism in amnestic mild cognitive impairment].
    Yu H; Zhang ZJ; Shi YM; Bai F; Qian Y; Yuan YG; Deng LL
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2008 Apr; 33(4):321-5. PubMed ID: 18460776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apolipoprotein E epsilon4, Alzheimer's disease, and cognitive performance in elderly Mexican Mestizos.
    Villalpando-Berumen JM; Mejia-Arango S; Aguilar-Salinas CA; Ordonez-Sanchez ML; Gutierrez-Robledo LM
    J Am Geriatr Soc; 2008 Apr; 56(4):677-82. PubMed ID: 18205760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergistic effect of apolipoprotein E epsilon4 and butyrylcholinesterase K-variant on progression from mild cognitive impairment to Alzheimer's disease.
    Lane R; Feldman HH; Meyer J; He Y; Ferris SH; Nordberg A; Darreh-Shori T; Soininen H; Pirttilä T; Farlow MR; Sfikas N; Ballard C; Greig NH
    Pharmacogenet Genomics; 2008 Apr; 18(4):289-98. PubMed ID: 18334913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apolipoprotein E genotype and mortality: findings from the Cache County Study.
    Hayden KM; Zandi PP; Lyketsos CG; Tschanz JT; Norton MC; Khachaturian AS; Pieper CF; Welsh-Bohmer KA; Breitner JC;
    J Am Geriatr Soc; 2005 Jun; 53(6):935-42. PubMed ID: 15935014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.